Publications by authors named "Ayako Ishimori"

Article Synopsis
  • The study explores the role of MAP3K19 in the epithelial-mesenchymal transition (EMT) and asthma, focusing on its uncertain involvement in these processes.
  • Researchers used a bronchial epithelial cell line and MAP3K19-deficient mice to examine how knocking down MAP3K19 affects cytokine production and airway inflammation.
  • Results showed that MAP3K19 reduces TWEAK-stimulated responses and allergic airway inflammation, suggesting its potential as a regulatory factor in asthma.
View Article and Find Full Text PDF
Article Synopsis
  • Mepolizumab treatment is effective in improving symptoms and quality of life in patients with severe eosinophilic asthma, but better biomarkers are needed to predict its effectiveness.
  • A study with 27 patients looked at various health indicators and also investigated the role of CD69-positive MAIT cells as potential biomarkers for treatment response.
  • Results showed that MAIT cell counts and serum periostin levels could help predict treatment outcomes, suggesting that MAIT cells may play a protective role against airway inflammation.
View Article and Find Full Text PDF
Article Synopsis
  • * A study involving 36 severe asthma patients showed that after 1 year of benralizumab treatment, there were notable changes in immune cell counts, including a reduction in eosinophils and basophils, alongside an increase in Th2 cells.
  • * The research indicates that circulating Th17 cell frequencies and FeNO levels could serve as predictive markers for patients' responsiveness to benralizumab treatment in a real-world context.
View Article and Find Full Text PDF

Background: Previous reports have shown that pathogen-associated patterns (PAMPs) induce the production of interleukin (IL)-1β in macrophages. Moreover, studies using mouse models also suggest that chitin, which acts as a PAMP, induces adjuvant effects and eosinophilic infiltration in the lung. Thus, we investigated the effects of inhaled chitin in mouse models.

View Article and Find Full Text PDF

Aim Of The Study: In patients with asthma, chronic inflammatory processes and the subsequent remodeling of the airways contribute to the symptoms and the pathophysiological changes. Epithelial-mesenchymal transition (EMT) is thought to play an important role in tissue remodeling. Previous reports show that tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) is a cytokine of the TNF superfamily, exerts pro-inflammatory effects, and enhances transforming growth factor (TGF)-β-induced EMT in bronchial epithelial cells.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the potential of serum tenascin-C (TNC) as a novel biomarker for asthma, alongside known markers like periostin and total IgE.
  • Researchers evaluated 126 adults with varying levels of asthma severity and found that higher serum TNC levels correlated with more severe disease.
  • The combination of high serum TNC with either high periostin or total IgE levels indicated increased asthma severity, suggesting that TNC could be a valuable addition to current asthma biomarkers.
View Article and Find Full Text PDF

Background: Fractional exhaled nitric oxide (FE) is useful for the evaluation of eosinophilic airway inflammation, including that seen in asthma. Although a new electrochemical hand-held FE analyzer, the NIOX VERO (Aerocrine AB, Solna, Sweden), is clinically convenient to use, it has not been fully compared with the chemiluminescence stationary electrochemical analyzer NOA280i (Sievers Instruments, Boulder, CO, USA) in terms of the level of measured FE. The aim of this study was to determine whether there is a difference between the two analyzers.

View Article and Find Full Text PDF

Although pneumococcal infection is a serious problem worldwide and has a high mortality rate, the molecular mechanisms underlying the lethality caused by pneumococcus remain elusive. Here, we show that BLT2, a G protein-coupled receptor for leukotriene B and 12(S)-hydroxyheptadecatrienoic acid (12-HHT), protects mice from lung injury caused by a pneumococcal toxin, pneumolysin (PLY). Intratracheal injection of PLY caused lethal acute lung injury (ALI) in BLT2-deficient mice, with evident vascular leakage and bronchoconstriction.

View Article and Find Full Text PDF

Background: A variety of innate subsets of lymphoid cells such as natural killer (NK) cells, several populations of innate lymphoid cells (ILCs), and mucosal-associated invariant T (MAIT) cells as innate-like T lymphocytes are involved in asthma and may have important effector functions in asthmatic immune responses. In the present study, we investigated whether NK cells, ILCs, and MAIT cells in the peripheral blood of patients with asthma would be associated with clinical asthma parameters.

Methods: We recruited 75 adult patients with mild to severe asthma.

View Article and Find Full Text PDF

Objective: Treatment guidelines for asthma recommend step-down therapy for well-controlled asthma patients. However, the precise strategy for step-down therapy has not been well defined. We investigated whether well-controlled patients with mild persistent asthma can tolerate a step-down therapy of either a reduced dose of inhaled corticosteroid (ICS) or a switch to a leukotriene receptor antagonist (LTRA), pranlukast hydrate.

View Article and Find Full Text PDF

Background:  Macrophages include the classically activated pro-inflammatory M1 macrophages (M1s) and alternatively activated anti-inflammatory M2 macrophages (M2s). The M1s are activated by both interferon-γ and Toll-like receptor ligands, including lipopolysaccharide (LPS), and have potent pro-inflammatory activity. In contrast, Th2 cytokines activate the M2s, which are involved in the immune response to parasites, promotion of tissue remodeling, and immune regulatory functions.

View Article and Find Full Text PDF